Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment

International Immunopharmacology

Volumn 9, Issue 4, 2009, Pages 403-411

  Oshio, Tomoyuki ^a   Sasaki, Yasuharu ^a   Funakoshi Tago, Megumi ^a   Aizu Yokota, Eriko ^a   Sonoda, Yoshiko ^a   Matsuoka, Hiroyuki ^b   Kasahara, Tadashi ^a  

^a KEIO UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Chemokines; Dermatophagoides farinae; NC Nga; Tacrolimus ointment protopic

Indexed keywords

EOTAXIN; EOTAXIN 2; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TACROLIMUS; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES FARINAE; DERMIS; DRUG EFFECT; EPIDERMIS; FEMALE; GENE EXPRESSION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLERGENS; ANIMALS; CHEMOKINES; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; MICE; OINTMENTS; TACROLIMUS;

EID: 61649125989     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.12.013     Document Type: Article

References (48)

1. Hoare C., Li Wan Po A., and Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 4 37 (2000) 1-191
2. Yamamoto M., Haruna T., Yasui K., Takahashi H., Iduhara M., Takaki S., et al. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. Allergol Intern 56 2 (2007) 139-148
3. Imokawa G., Abe A., Jin K., Higaki Y., Kawashima M., and Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis an etiologic factor in atopic dry skin. J Invest Dermatol 96 4 (1991) 523-526
4. Soter N.A. Morphology of atopic eczema. Allergy 44 Suppl 9 (1989) 16-19
5. Grewe M., Walther S., Gyufko K., Czech W., Schöpf E., and Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105 3 (1995) 407-410
6. Grewe M., Bruijnzeel-Koomen C.A., Schöpf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19 8 (1998) 359-361
7. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 9352 (2003) 151-160
8. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 2 (2005) 135-142
9. Jamieson T., and Cook D.N. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 6 4 (2005) 403-411
10. Homey B., Steinhoff M., Ruzicka T., and Leung D.Y. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118 1 (2006) 178-189
11. Jahnz-Rozyk K., Targowski T., Paluchowska E., Owczarek W., and Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60 5 (2005) 685-688
12. Shimada Y., Takehara K., and Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 34 3 (2004) 201-208
13. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 127 2 (2002) 270-273
14. Kaburagi Y., Shimada Y., Nagaoka T., Hasegawa M., Takehara K., and Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha,MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293 7 (2001) 350-355
15. Taha R.A., Minshall E.M., Leung D.Y., Boguniewicz M., Luster A., Muro S., et al. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol 105 5 (2000) 1002-1007
16. Kagami S., Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Nakamura K., et al. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 134 2 (2003) 309-313
17. Ochi H., Hirani W.M., Yuan Q., Friend D.S., Austen K.F., and Boyce J.A. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190 2 (1999) 267-280
18. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171 10 (2005) 1103-1108
19. Juremalm M., Olsson N., and Nilsson G. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 297 3 (2002) 480-485
20. Nakayama T., Fujisawa R., Yamada H., Horikawa T., Kawasaki H., Hieshima K., et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 13 1 (2001) 95-103
21. Vanbervliet B., Homey B., Durand I., Massacrier C., Aït-Yahia S., de Bouteiller O., et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol 32 1 (2002) 231-242
22. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104 8 (1999) 1097-1105
23. + T cells initiate atopic dermatitis lesions. J Immunol 178 9 (2007) 5571-5577
24. Matsuoka H., Maki N., Yoshida S., Arai M., Wang J., Oikawa Y., et al. A mouse model of the atopic eczemadermatitis syndrome by repeated application of a crude extract of housedust mite Dermatophagoides farina. Allergy 58 2 (2003) 139-145
25. Kuraishi Y., Nagasawa T., Hayashi K., and Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 275 3 (1995) 229-233
26. Dong H., Toyoda N., Yoneyama H., Kurachi M., Kasahara T., Kobayashi Y., et al. Gene expression profile analysis of the mouse liver during bacteria-induced fulminant hepatitis by a cDNA microarray system. Biochem Biophys Res Commun 298 5 (2002) 675-686
27. Sasakawa T., Higashi Y., Sakuma S., Hirayama Y., Sasakawa Y., Ohkubo Y., et al. Topical application of FK506 (tacrolimus) ointment inhibits mite antigen-induced dermatitis by local action in NC/Nga mice. Int Arch Allergy Immunol. 133 1 (2004) 55-63
28. Inagaki N., Shiraishi N., Igeta K., Itoh T., Chikumoto T., Nagao M., et al. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol. 546 1-3 (2006) 189-196
29. Rustin M.H. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. Br J Dermatol 157 5 (2007) 861-873
30. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol 9 3 (1997) 461-466
31. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
32. Gu L., Tseng S., Horner R.M., Tam C., Loda M., and Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404 6776 (2000) 407-411
33. Carr M.W., Roth S.J., Luther E., Rose S.S., and Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 91 9 (1994) 3652-3656
34. Inngjerdingen M., Damaj B., and Maghazachi A.A. Expression and regulation of chemokine receptors in human natural killer cells. Blood. 97 2 (2001) 367-375
35. Jose P.J., Griffiths-Johnson D.A., Collins P.D., Walsh D.T., Moqbel R., Totty N.F., et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179 3 (1994) 881-887
36. White J.R., Imburgia C., Dul E., Appelbaum E., O'Donnell K., O'Shannessy D.J., et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 62 5 (1997) 667-675
37. Forssmann U., Uguccioni M., Loetscher P., Dahinden C.A., Langen H., Thelen M., et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 185 12 (1997) 2171-2176
38. Uguccioni M., Mackay C.R., Ochensberger B., Loetscher P., Rhis S., LaRosa G.J., et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100 5 (1997) 1137-1143
39. Sallusto F., Mackay C.R., and Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277 5334 (1997) 2005-2007
40. Tsunemi Y., Saeki H., Nakamura K., Nagakubo D., Nakayama T., Yoshie O., et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol 36 8 (2006) 2116-2127
41. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 2 (2000) 121-127
42. Godiska R., Chantry D., Raport C.J., Sozzani S., Allavena P., Leviten D., et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185 9 (1997) 1595-1604
43. Horikawa T., Nakayama T., Hikita I., Yamada H., Fujisawa R., Bito T., et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine /CCL17 and macrophage-derived chemokine /CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int. Immunol 14 (2002) 767-773
44. Liddiard K., Welch J.S., Lozach J., Heinz S., Glass C.K., and Greaves D.R. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol Biol 7 (2006) 45
45. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 5439 (1999) 525-528
46. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Aït-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 2 (1998) 373-386
47. Starner T.D., Barker C.K., Jia H.P., Kang Y., and McCray Jr. P.B. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 29 5 (2003) 627-633
48. Hiroi J., Sengoku T., Morita K., Kishi S., Sato S., Ogawa T., et al. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn J Pharmacol 76 2 (1998) 175-183